Cord blood is a valuable source of hematopoietic stem cells (HSCs), also known as blood-forming stem cells. These stem cells are widely used in the treatment of various blood disorders because they have the ability to adapt, self-renew, and regenerate.
HSCs help restore healthy blood formation by replacing damaged or malfunctioning bone marrow. Also, they can offer an effective alternative to bone marrow transplantation, especially for individuals who are unable to find a suitable donor match.
Cord blood stem cell transplantation is used in the treatment of several blood disorders such as sickle cell anemia, Fanconi anemia, severe aplastic anemia, thalassemia, bone marrow failure syndromes, thrombocytopenia, etc.
These cells have also shown the potential ability to treat inherited metabolic diseases and other blood-related conditions.
Blood disorders often happen when the bone marrow is unable to produce sufficient healthy blood cells. After transplantation, hematopoietic stem cells travel to the bone marrow and start producing new, healthy blood cells. This helps redevelop the blood and immune systems, improving the normal blood cell production.
Researchers are working on advanced therapies using stem cell technologies for platelets, red blood cells, and immune cell regeneration.
